Gap Junctions in Vascular Smooth Muscle: Growth Control
Gap Junctions in Vascular Smooth Muscle: Growth Control
批准号:
8049457
负责人:
JANIS M BURT
金额:
$37.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-07-15 至 2014-11-30
关键词:
AcuteAddressBindingBiological ModelsBlood VesselsBlood flowCell CycleCell Cycle ArrestCell Cycle ProgressionCell Cycle RegulationCell LineCell ProliferationCell WallCellsChemicalsClinicalConnexin 43ConnexinsCytoplasmic TailDataDevelopmentDiseaseElectrophysiology (science)ElementsEndothelial CellsEndotheliumEventFluorescence MicroscopyGap JunctionsGiant CellsGoalsGrowthGrowth FactorHealthHeart AtriumHindlimbHormonesIn VitroInjuryIschemiaKnowledgeLeadMediatingModelingMolecularMusMuscle CellsPermeabilityPharmacy (field)PhosphorylationPredispositionProcessProliferatingPropertyProteinsPublishingRecoveryRegulationRelative (related person)RelaxationResearchRoleSignal TransductionSiteSmooth MuscleSpeedStressTestingTissuesVascular ProliferationVascular Smooth MuscleVascular remodelingVentricularWorkangiogenesisbaseconnexin 37cytokinegap junction channelgene therapyin vivoinjuredinsightintercellular communicationparticlereceptorresponseresponse to injuryrestorationvasculogenesisvoltage
中文摘要
描述(由申请人提供):本研究的长期目标是:1)了解控制血管细胞间隙连接的渗透性和生长抑制特性的分子机制;2)从这些知识中发展针对内皮细胞连接蛋白表达的基因治疗的基本原理,目的是限制对缺血性损伤的易感性并促进其恢复。三种间隙连接蛋白在血管细胞中普遍表达:connexin (Cx) 37、Cx40和Cx43;在内皮细胞中,Cx37和Cx40通常占主导地位,但在血管形成和应激、损伤和疾病期间,Cx37下调,Cx43上调。在血管重塑过程中,这种表达变化对血管形成新血管和维持血管功能的影响尚不清楚。在我们之前的研究中,我们证明了这些连接蛋白形成的缝隙连接通道具有截然不同的过选择性和生长抑制特性,这些特性由生长因子激活的信号级联以连接蛋白特异性的方式调节。在目前的建议中,我们假设连接蛋白特异性;磷酸化依赖性的连接过选择性调控为血管细胞提供了一种维持血管协调收缩/舒张功能的策略,同时支持血管细胞的增殖反应。我们在Aim 1中通过研究羧基末端结构域(CT)的磷酸化事件如何导致相关孔结构域的过选择性改变的机制基础来解决这一假设。在目标2中,我们扩展了目标1的观察结果,并确定这些连接蛋白的生长抑制特性是否依赖于它们的过选择特性和/或它们与参与细胞周期控制和进展的蛋白质的直接相互作用。这些生长研究利用cx缺陷细胞系、从野生型或Cx37缺陷小鼠中分离的内皮细胞以及体内后肢缺血性损伤模型,研究Cx37是否与Cx43联合或相反地调节损伤诱导的血管生成反应,同时保持连接的过选择性。电生理学和荧光显微镜的结合将用于量化连接的超选择性特性,分子方法将用于确定连接蛋白域之间以及连接蛋白与细胞周期机制元件之间相互作用的基本区域/位置。将使用分离的内皮细胞和体内缺血模型来确定连接蛋白表达或沉默对损伤后血管重构的程度和速度的益处。我们的研究有望为血管连接蛋白的通透性和生长抑制功能的磷酸化依赖性调节的机制基础提供新的见解,并可能使用基因治疗来操纵内皮中的连接蛋白表达,以适当地在血管损伤和疾病的情况下最大化/最小化血管生成。
英文摘要
DESCRIPTION (provided by applicant): The long-term goals of this research are: 1) to understand the molecular mechanisms that govern the permeability and growth suppressive properties of vascular cell gap junctions and 2) to develop from that knowledge the rationale for gene therapies that target connexin expression in endothelial cells with the goal of limiting susceptibility to and facilitating recovery from ischemic injury. Three gap junction proteins are commonly expressed in vascular cells, connexin (Cx) 37, Cx40 and Cx43; in the endothelium Cx37 and Cx40 normally predominate, but during vasculogenesis and with stress, injury and disease, Cx37 is down-regulated and Cx43 up-regulated. The consequences of this change in expression on the vessel's ability to form new vessels and to maintain vessel functions during vascular remodeling remain uncertain. In our previous studies, we demonstrated that these connexins form gap junction channels with vastly different permselective and growth suppressive properties that are regulated by growth factor activated signaling cascades in a connexin- specific manner. In the current proposal we hypothesize that connexin-specific; phosphorylation-dependent regulation of junctional permselectivity provides vascular cells a strategy for maintaining coordinated contraction/relaxation functions of vessels while simultaneously supporting the proliferative response of cells therein. We address this hypothesis in Aim 1 by examining the mechanistic basis for how phosphorylation events in the carboxyl terminal domain (CT) lead to altered permselective properties of the associated pore domain. In aim 2 we extend the observations of Aim 1 and determine whether the growth suppressive properties of these connexins rely on their permselective properties and/or their direct interactions with proteins involved in cell cycle control and progression. These growth studies make use of Cx-deficient cell lines, endothelial cells isolated from wild type or Cx37 deficient mice, and an in vivo hindlimb ischemic injury model, asking whether Cx37 works in conjunction with or in opposition to Cx43 to regulate the angiogenic response induced by injury while preserving junctional permselective properties. A combination of electrophysiology and fluorescence microscopy will be used to quantify the permselective properties of junctions and molecular approaches will be used to identify essential regions/sites of interaction between connexin domains and between connexins and elements of the cell cycle machinery. Isolated endothelial cells and an in vivo ischemia model will be used to determine the benefit of connexin expression or silencing to the extent and speed of vascular remodeling following injury. Our studies can be expected to lend new insights on the mechanistic basis for phosphorylation-dependent regulation of the permeability and growth suppressive functions of the vascular connexins and to the possible use of gene therapy to manipulate connexin expression in the endothelium to maximize/minimize angiogenesis, as appropriate, in settings of vascular injury and disease.
PUBLIC HEALTH RELEVANCE: Successful recovery of tissues from ischemic and traumatic injury requires restoration of blood flow through a process that involves regulated proliferation of vascular cells. Gap junctions and their comprising proteins, the connexins, serve as regulators of cell proliferation. Three connexins are expressed in vascular cells; we are studying how the function of these connexins and the intercellular communication channels they comprise is regulated in normal and pathological settings. Insights gained from our studies may help in the development of clinical strategies that will facilitate more rapid and complete recovery of tissue function following ischemic or traumatic injuries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phosphorylation and gating of cardiac connexin channels
-
批准号:9078759
-
项目类别:
-
资助金额:$39.57万
-
财政年份:2016
-
负责人:JANIS M BURT
-
依托单位:
Role of Connexin47 mutations in primary lymphedema
-
批准号:8831729
-
项目类别:
-
资助金额:$18.65万
-
财政年份:2014
-
负责人:JANIS M BURT
-
依托单位:
Role of Connexin47 mutations in primary lymphedema
-
批准号:8677486
-
项目类别:
-
资助金额:$18.94万
-
财政年份:2014
-
负责人:JANIS M BURT
-
依托单位:
Role of Gap Junctions in Blood Vessel Assembly
-
批准号:8267618
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2009
-
负责人:JANIS M BURT
-
依托单位:
Role of Gap Junctions in Blood Vessel Assembly
-
批准号:7901514
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2009
-
负责人:JANIS M BURT
-
依托单位:
Role of Gap Junctions in Blood Vessel Assembly
-
批准号:7750472
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2009
-
负责人:JANIS M BURT
-
依托单位:
Role of Gap Junctions in Blood Vessel Assembly
-
批准号:8452686
-
项目类别:
-
资助金额:$39.62万
-
财政年份:2009
-
负责人:JANIS M BURT
-
依托单位:
GAP JUNCTIONS IN VASCULAR SMOOTH MUSCLE--GROWTH CONTROL
-
批准号:6030845
-
项目类别:
-
资助金额:$20.91万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
Gap Junctions in Vascular Smooth Muscle: Growth Control
-
批准号:8209153
-
项目类别:
-
资助金额:$37.88万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
Gap junctions in Vascular Smooth Muscle: growth control
-
批准号:7039119
-
项目类别:
-
资助金额:$33.15万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
Gap junctions in Vascular Smooth Muscle: growth control
-
批准号:6929542
-
项目类别:
-
资助金额:$33.86万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
Gap junctions in Vascular Smooth Muscle: growth control
-
批准号:7575801
-
项目类别:
-
资助金额:$32.21万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
GAP JUNCTIONS IN VASCULAR SMOOTH MUSCLE--GROWTH CONTROL
-
批准号:6194449
-
项目类别:
-
资助金额:$26.11万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
Gap Junctions in Vascular Smooth Muscle: Growth Control
-
批准号:8583331
-
项目类别:
-
资助金额:$37.12万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
GAP JUNCTIONS IN VASCULAR SMOOTH MUSCLE--GROWTH CONTROL
-
批准号:2735394
-
项目类别:
-
资助金额:$20.07万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
Gap Junctions in Vascular Smooth Muscle: Growth Control
-
批准号:8386975
-
项目类别:
-
资助金额:$36.06万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
Gap junctions in Vascular Smooth Muscle: growth control
-
批准号:7185786
-
项目类别:
-
资助金额:$32.21万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
GAP JUNCTIONS IN VASCULAR SMOOTH MUSCLE--GROWTH CONTROL
-
批准号:6537333
-
项目类别:
-
资助金额:$26.51万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
GAP JUNCTIONS IN VASCULAR SMOOTH MUSCLE--GROWTH CONTROL
-
批准号:6389722
-
项目类别:
-
资助金额:$26.11万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
Gap junctions in Vascular Smooth Muscle: growth control
-
批准号:7367201
-
项目类别:
-
资助金额:$32.21万
-
财政年份:1997
-
负责人:JANIS M BURT
-
依托单位:
海外基金